- call +1-201-465-4211
- email sales@mrinsights.biz
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
Scope of the Report:
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.
The worldwide market for Biologics and Biosimilars is expected to grow at a CAGR of roughly 4.5% over the next five years, will reach 272400 million US$ in 2024, from 209400 million US$ in 2019, according to a new study.
This report focuses on the Biologics and Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars in 2017 and 2018.
Chapter 3, the Biologics and Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies
1.2.2 Interferon
1.2.3 Erythropoietin
1.2.4 Insulin
1.2.5 Vaccines
1.2.6 Other
1.3 Market Analysis by Applications
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Biologics and Biosimilars Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Biologics and Biosimilars Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Biologics and Biosimilars Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi-Aventis
2.4.1 Business Overview
2.4.2 Biologics and Biosimilars Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Biologics and Biosimilars Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Biologics and Biosimilars Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Biologics and Biosimilars Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Biologics and Biosimilars Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Biologics and Biosimilars Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Merck
2.10.1 Business Overview
2.10.2 Biologics and Biosimilars Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 3sbio
2.11.1 Business Overview
2.11.2 Biologics and Biosimilars Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Changchun High Tech
2.12.1 Business Overview
2.12.2 Biologics and Biosimilars Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 CP Guojian
2.13.1 Business Overview
2.13.2 Biologics and Biosimilars Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Biotech
2.14.1 Business Overview
2.14.2 Biologics and Biosimilars Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Gelgen
2.15.1 Business Overview
2.15.2 Biologics and Biosimilars Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Innovent
2.16.1 Business Overview
2.16.2 Biologics and Biosimilars Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Dong Bao
2.17.1 Business Overview
2.17.2 Biologics and Biosimilars Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Ganlee
2.18.1 Business Overview
2.18.2 Biologics and Biosimilars Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biologics and Biosimilars Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2018
3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Biologics and Biosimilars Market Analysis by Regions
4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2014-2019)
4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2014-2019)
4.2 North America Biologics and Biosimilars Sales and Growth Rate (2014-2019)
4.3 Europe Biologics and Biosimilars Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2014-2019)
4.5 South America Biologics and Biosimilars Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2014-2019)
5 North America Biologics and Biosimilars by Country
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2014-2019)
5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2014-2019)
5.2 United States Biologics and Biosimilars Sales and Growth Rate (2014-2019)
5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2014-2019)
5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2014-2019)
6 Europe Biologics and Biosimilars by Country
6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Country (2014-2019)
6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Country (2014-2019)
6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2014-2019)
6.3 UK Biologics and Biosimilars Sales and Growth Rate (2014-2019)
6.4 France Biologics and Biosimilars Sales and Growth Rate (2014-2019)
6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2014-2019)
6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2014-2019)
7 Asia-Pacific Biologics and Biosimilars by Country
7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Country (2014-2019)
7.2 China Biologics and Biosimilars Sales and Growth Rate (2014-2019)
7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2014-2019)
7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2014-2019)
7.5 India Biologics and Biosimilars Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2014-2019)
8 South America Biologics and Biosimilars by Country
8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Biologics and Biosimilars Sales and Market Share by Country (2014-2019)
8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Country (2014-2019)
8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2014-2019)
8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2014-2019)
8.4 Colombia Biologics and Biosimilars Sales and Growth Rate (2014-2019)
9 Middle East and Africa Biologics and Biosimilars by Countries
9.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Biologics and Biosimilars Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Biologics and Biosimilars Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2014-2019)
9.3 Turkey Biologics and Biosimilars Sales and Growth Rate (2014-2019)
9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2014-2019)
9.5 Nigeria Biologics and Biosimilars Sales and Growth Rate (2014-2019)
9.6 South Africa Biologics and Biosimilars Sales and Growth Rate (2014-2019)
10 Global Biologics and Biosimilars Market Segment by Type
10.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Biologics and Biosimilars Sales and Market Share by Type (2014-2019)
10.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2014-2019)
10.2 Monoclonal Antibodies Sales Growth and Price
10.2.1 Global Monoclonal Antibodies Sales Growth (2014-2019)
10.2.2 Global Monoclonal Antibodies Price (2014-2019)
10.3 Interferon Sales Growth and Price
10.3.1 Global Interferon Sales Growth (2014-2019)
10.3.2 Global Interferon Price (2014-2019)
10.4 Erythropoietin Sales Growth and Price
10.4.1 Global Erythropoietin Sales Growth (2014-2019)
10.4.2 Global Erythropoietin Price (2014-2019)
10.5 Insulin Sales Growth and Price
10.5.1 Global Insulin Sales Growth (2014-2019)
10.5.2 Global Insulin Price (2014-2019)
10.6 Vaccines Sales Growth and Price
10.6.1 Global Vaccines Sales Growth (2014-2019)
10.6.2 Global Vaccines Price (2014-2019)
10.7 Other Sales Growth and Price
10.7.1 Global Other Sales Growth (2014-2019)
10.7.2 Global Other Price (2014-2019)
11 Global Biologics and Biosimilars Market Segment by Application
11.1 Global Biologics and Biosimilars Sales Market Share by Application (2014-2019)
11.2 Tumor Sales Growth (2014-2019)
11.3 Diabetes Sales Growth (2014-2019)
11.4 Cardiovascular Sales Growth (2014-2019)
11.5 Hemophilia Sales Growth (2014-2019)
11.6 Other Sales Growth (2014-2019)
12 Biologics and Biosimilars Market Forecast (2019-2024)
12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2019-2024)
12.2 Biologics and Biosimilars Market Forecast by Regions (2019-2024)
12.2.1 North America Biologics and Biosimilars Market Forecast (2019-2024)
12.2.2 Europe Biologics and Biosimilars Market Forecast (2019-2024)
12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2019-2024)
12.2.4 South America Biologics and Biosimilars Market Forecast (2019-2024)
12.2.5 Middle East and Africa Biologics and Biosimilars Market Forecast (2019-2024)
12.3 Biologics and Biosimilars Market Forecast by Type (2019-2024)
12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2019-2024)
12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2019-2024)
12.4 Biologics and Biosimilars Market Forecast by Application (2019-2024)
12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2019-2024)
12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biologics and Biosimilars Picture
Table Product Specifications of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
